Cervical cancer is one of the most preventable cancers. However, the latest Globocan data estimated 311,000 women died from cervical cancer globally. Most of these deaths occurred in low- and lower-middle income countries (LMICs) due to inadequate access to cervical cancer prevention, early detection, treatment and palliative care and it is the poorest and marginalised communities that are suffering the most.
In November 2020, the WHO launched a global strategy to accelerate the elimination of cervical cancer as a public health problem. The Strategy proposes an elimination threshold of 4 cases per 100,000 women, achieved by implementing the triple intervention targets by 2030. Despite the decision to move to a virtual 73rd World Health Assembly (WHA) with a sole focus on COVID-19 in May 2020, Member States were able to adopt the WHO Global Strategy for elimination of cervical cancer via ‘silence procedure’ followed by an official launch of the Global Strategy at a virtual event on 17 November and celebration of this landmark decision as a once-in-a-generation opportunity to eliminate one of the deadliest, but also most preventable and successfully treatable, forms of cancer for women.
Harnessing this momentum, we now need to ensure that global commitments are translated to national action with improved and equitable access to HPV vaccination, HPV-DNA screening and management of pre-cancers and cancers. In this three-session series UICC and Jhpiego will bring global health leaders, advocates and policymakers together to discuss the challenges and solutions to creating an enabling environment which will accelerate towards the 90:70:90 targets by 2030.
The Cervical Cancer Elimination series is delivered in partnership with Jhpiego
Upcoming dialogues in the series, including registration links, will appear below as soon as confirmed. On-demand recordings of past dialogues will also be accessible below once the live event as taken place.